You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Dobutamine Hydrochloride In Dextrose 5% patents expire, and when can generic versions of Dobutamine Hydrochloride In Dextrose 5% launch?

Dobutamine Hydrochloride In Dextrose 5% is a drug marketed by Hospira and Baxter Hlthcare and is included in three NDAs.

The generic ingredient in DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% is dobutamine hydrochloride. There are fourteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dobutamine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Dobutamine Hydrochloride In Dextrose 5%

A generic version of DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% was approved as dobutamine hydrochloride by HOSPIRA on November 29th, 1993.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%?
  • What are the global sales for DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%?
  • What is Average Wholesale Price for DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%?
Summary for DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%
Drug patent expirations by year for DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%
Recent Clinical Trials for DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. IliescuN/A
Koç UniversityN/A
Wuhan Union Hospital, ChinaPhase 2/Phase 3

See all DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% clinical trials

US Patents and Regulatory Information for DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% dobutamine hydrochloride INJECTABLE;INJECTION 020269-001 Oct 19, 1993 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER dobutamine hydrochloride INJECTABLE;INJECTION 020255-005 Oct 19, 1993 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER dobutamine hydrochloride INJECTABLE;INJECTION 020255-001 Oct 19, 1993 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.